Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 77

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4
Chunk 77
---
 traits. Evogene’s proprietary CPB platform, specifically, the GeneRator AI engine, validation techniques and other capabilities enable us to identify and optimize promising genetic elements that have the potential to improve our traits of interest in target crops.

                                                                      ________________________                                                                     
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
3 https://www.un.org/en/chronicle/article/feeding-world-sustainably                                                                                                
4 https://www.researchandmarkets.com/reports/5141331/gmo-crops-and-seeds-global-strategic-business?srsltid=AfmBOoowCJCSxzLjrh5aKFzKy2jqrTfNNaLm_PO8w_Z8RHHnAVKZzqV5
Product Development Cycle
 
 The length of the process of developing and integrating seed traits may vary depending on the technology being applied, the complexity of the trait and the type of crop involved. The development process for seed traits is typically divided into discrete steps, or phases, as follows:

◾                                      Discovery: The identification of target genetic elements for enhancing                                   
     specified plant traits. We test these elements in different validation systems to determine their ability to enhance the specified trait.  
    In our experience, the Discovery phase takes approximately 6-18 months. The target genetic elements may be applicable to product development
      through different technological approaches (i.e. genome editing, GM or advanced breeding). In our collaborations, we typically undertake  
                                                                    this phase.                                                                 
------------------------------------------------------------------------------------------------------------------------------------------------

◾                                           Phase I, or “Proof of Concept”: Validated candidate genetic                                         
      elements are advanced to Phase I. In this phase, they are tested in target plants through greenhouse trials, field trials, or both, for   
       their efficacy in improving plant performance. Phase I may be conducted by us or by our collaborators, and in our experience, may last   
    between two to five years for a GM product or, three years for a genome editing or advanced breeding product. For products developed through
                  genome editing, deregulation process for classifying a product as non-GM is typically initiated during Phase I.               
------------------------------------------------------------------------------------------------------------------------------------------------

◾                                              Phase II, or “Early Development”: In this phase, the field                                          
    tests are expanded, and our collaborators evaluate the genetic elements on multiple geographical locations and varieties, to reach commercially
         viable success rates. We estimate the duration of Phase II is between two to four years. For a GM product, by the end of this phase, a    
        specific product candidate